Correlation Between PaxMedica, Common and Anebulo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both PaxMedica, Common and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PaxMedica, Common and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PaxMedica, Common Stock and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on PaxMedica, Common and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PaxMedica, Common with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PaxMedica, Common and Anebulo Pharmaceuticals.

Diversification Opportunities for PaxMedica, Common and Anebulo Pharmaceuticals

0.64

Correlation Coefficient

PaxMedica, Common  Anebulo Pharmaceuticals

Poor diversification

The 3 months correlation between PaxMedica, and Anebulo is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding PaxMedica, Common Stock and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and PaxMedica, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PaxMedica, Common Stock are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of PaxMedica, Common i.e., PaxMedica, Common and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between PaxMedica, Common and Anebulo Pharmaceuticals

If you would invest  86.00  in PaxMedica, Common Stock on September 5, 2024 and sell it today you would earn a total of  0.00  from holding PaxMedica, Common Stock or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	4.55%
Values	Daily Returns

PaxMedica, Common Stock  vs.  Anebulo Pharmaceuticals

PaxMedica, Common Stock

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PaxMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, PaxMedica, Common is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Anebulo Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Anebulo Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical and fundamental indicators, Anebulo Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with PaxMedica, Common and Anebulo Pharmaceuticals

The main advantage of trading using opposite PaxMedica, Common and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PaxMedica, Common position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.

The idea behind PaxMedica, Common Stock and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.